Your browser doesn't support javascript.
loading
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.
Cohn, Danny M; Aygören-Pürsün, Emel; Bernstein, Jonathan A; Farkas, Henriette; Lumry, William R; Maurer, Marcus; Zanichelli, Andrea; Iverson, Matthew; Hao, James; Smith, Michael D; Yea, Christopher M; Audhya, Paul K; Riedl, Marc A.
Afiliación
  • Cohn DM; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Aygören-Pürsün E; Department for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany.
  • Bernstein JA; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Farkas H; Hungarian Angioedema Center of Reference and Excellence, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.
  • Lumry WR; AARA Research Center, Dallas, Texas, USA.
  • Maurer M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Zanichelli A; Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
  • Iverson M; Operative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato, Milan, Italy.
  • Hao J; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
  • Smith MD; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Yea CM; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Audhya PK; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Riedl MA; KalVista Pharmaceuticals, Salisbury, UK.
Clin Transl Allergy ; 13(9): e12288, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37746795

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Transl Allergy Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Transl Allergy Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos